Curaleaf’s medical retail presence grows to 17 locations in Pennsylvania
June 16, 2022 — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today announced the opening of its Lancaster dispensary, located at 1440 Manheim Pike Lancaster, PA 17601. Curaleaf Lancaster is the Company’s fifth new location to open within the Keystone State this year, expanding its retail presence to 17 locations in Pennsylvania and 134 nationwide, with more expansion planned in the state for 2022.
Curaleaf Lancaster offers a curated selection of products across its brand portfolio spanning Grassroots, Select and Curaleaf. Patients can choose from a wide array of premium cannabis products, including Select Elite, Select Elite Live, Grassroots full-spectrum and strain-specific RSO, Grassroots full-spectrum and strain specific RSO capsules, Grassroots pre-packaged flower, Curaleaf pre-packaged flower, Grassroots concentrates and Grassroots THC tablets.
The Company will celebrate the dispensary’s soft opening on June 16, followed by a grand opening event on June 23. The celebration will feature a ribbon cutting ceremony at 8:45 a.m. ET with the Lancaster Chamber of Commerce and vendor pop-ups from 12:00 p.m. to 2:00 p.m. ET. Curaleaf also commemorated its latest dispensary opening by making a $5,000 donation to the Lancaster County Food Hub, a local nonprofit that offers free food, clothing and shelter to community members.
“Pennsylvania has become one of the fastest growing medical markets in the nation and we are proud to be able to widen access to patients across the state,” said Matt Darin, Chief Executive Officer of Curaleaf. “Curaleaf Lancaster is the Company’s first dispensary in Lancaster County. It will allow us to introduce ourselves to new communities while supplying quality products and helping patients make informed decisions about incorporating medical marijuana into their lives.”
In addition to Curaleaf’s latest locations, the Company also serves patients in Altoona, Bradford, Brookville, City Avenue, DuBois, Erie, Gettysburg, Greensburg, Harrisburg, Horsham, King of Prussia, Lebanon, Morton, Philadelphia, State College, and Wayne. This summer, Curaleaf plans to open a location in Allentown, further expanding its footprint in Pennsylvania to 18 locations.
For more information regarding Curaleaf’s product offerings in Pennsylvania, along with openings and hours of operation, please visit https://curaleaf.com/dispensary/pennsylvania.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 22 states with 134 dispensaries, 26 cultivation sites, and employs over 5,700 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
